Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2021-03-19 Regulatory Filings
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1927 characters) and contains the header 'RNS Number : 8552S'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement distributed via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, or DLST), the most appropriate fallback category is Regulatory Filings (RNS).
2021-03-19 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1910 characters) and contains the header 'RNS Number : 8544S'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It does not contain detailed financial statements, management discussion, or formal meeting materials. Instead, it is a brief, specific operational announcement disseminated via the RNS service, which is approved by the FCA to act as a Primary Information Provider. Given its nature as a short, specific regulatory/market operational update that doesn't fit the other specific categories (like DIV, DIRS, ER, etc.), it best fits the general 'Regulatory Filings' fallback category, which often captures these types of RNS market notices.
2021-03-19 English
Initiation of research by Allenby Capital
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number '8718R' and explicitly states it is a 'REACH: non-regulatory announcement'. The content announces that the company's broker, Allenby Capital, has initiated research on the company and provides a link to that research. This is not a primary financial report (like 10-K or IR), nor is it a formal regulatory filing concerning financial results, management changes, or shareholder votes. Since it is an announcement about external research availability, and it is explicitly labeled as 'non-regulatory' distributed via the RNS/Reach service, it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous non-core announcements, especially those distributed through the RNS platform that aren't covered by more specific codes. Given the short length and the nature of announcing external information, RNS is the most appropriate classification.
2021-03-11 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1927 characters) and contains the header 'RNS Number : 8046R'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This type of brief, immediate market operational announcement, especially one explicitly labeled with an 'RNS Number' and distributed by the LSE's news service, fits best under the general Regulatory Filings category, as it does not correspond to any of the specific financial report types (like 10-K, ER, IR) or corporate action types (like DIV, CAP, MANG). It is a standard regulatory notification.
2021-03-10 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1910 characters) and contains the header 'RNS Number : 8038R'. It announces a 'Price Monitoring Extension' for a security, which is a specific, non-standard market operational update. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the FCA as a Primary Information Provider. Since this is a specific, non-standard regulatory announcement that doesn't fit into the defined categories like ER, IR, or DIRS, and it is an official notification distributed via the RNS system, the most appropriate classification is the general regulatory filing fallback category.
2021-03-10 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1927 characters) and contains the header 'RNS Number : 7768R'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or DLST), the most appropriate fallback category is Regulatory Filings (RNS).
2021-03-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.